As anti-obesity medications like Ozempic and Wegovy become increasingly popular, American employees are making career choices based on access to them. A recent poll found that 1 in 5 Americans would be willing to switch jobs to get insurance coverage for these in-demand medications. But as the craze for GLP-1 drugs takes hold of the workforce, the question is—are we becoming a healthier society, or merely taking a medically approved shortcut?

In a world where job benefits such as remote work, unlimited time off, and child care allowances drive the benefits discussion, there's a new player in the mix: weight loss drugs. A 2024 survey by 9amHealth found that 67% of Americans would remain at a job they disliked if it included retaining access to drugs such as Ozempic and Wegovy. And if workplaces don't pay for them? 20% of respondents would actively seek another job.

This behavior is not without purpose. Out-of-pocket expenses for GLP-1 medications such as Ozempic can run over $1,000 monthly. Confronted with this expense, some users report skimping on necessities such as food and entertainment in order to pay for their monthly supply. Coverage under employer-sponsored insurance, thus, becomes not only a benefit—but a necessity.

What is the Frenzy of GLP-1 Drugs?

Contrary to older weight loss drugs that normally achieve a 5% drop in body weight, newer GLP-1 medications provide up to 20% weight loss or more. Their impact has been so significant that Science identified GLP-1 medications as the 2023 "Breakthrough of the Year." The medications act by emulating a hormone that controls blood glucose and hunger, leading to both enhanced metabolic function and reduced hunger.

Initially approved for type 2 diabetes, Ozempic and other medications such as Mounjaro have been used extensively off-label for weight loss, driving stratospheric demand. In February 2023 alone, over 373,000 prescriptions for Ozempic were filled—a 111% increase from the year before.

Ozempic: High Demand, Higher Costs, and Potential Misuse

But with increasing demand comes increasing expense. Ozempic and Mounjaro were among 800 drugs that experienced a median list price increase of 4.5% this year, the Wall Street Journal reported. Some large institutions, such as Ascension Health and the University of Texas System, have even withdrawn coverage in light of skyrocketing prices—reporting a 233% increase in expenditures related to them.

According to the World Health Organization, over 80% of people with type 2 diabetes are overweight or obese. Chronic inflammation caused by excess fat, especially visceral fat, disrupts how insulin functions. Additionally, high levels of circulating fatty acids can impair insulin sensitivity.

Dr. Arush Sabharwal, Bariatric & Metabolic Surgeon explains, "This is where GLP-1 receptor agonists like Ozempic (semaglutide) come into the picture. Originally approved for type 2 diabetes, Ozempic also promotes weight loss by suppressing appetite and slowing gastric emptying. Clinical trials have shown significant weight reduction and improved blood sugar control in patients using it."

"Though Ozempic is not a magic solution, still it denotes a powerful association between the role of weight management and type 2 diabetes. For those who are overweight, lifestyle modifications are important, after seeking professional advice from a weight loss expert like a doctor/bariatric surgeon/certified nutritionist."

There's also an increasing worry about the abuse and stigma surrounding these medications. Although Ozempic is now a cultural buzzword and an alleged "magic bullet" for rapid weight loss, physicians warn that it's not a sustainable solution in and of itself. "Without robust support for behavior change, weight loss is generally short-term and tends to be followed by weight regain," experts in endocrinology and metabolic care stated.

In fact, 38% of respondents to the 9amHealth poll confessed to exploring black market sources prior to settling on FDA-accepted treatments—courageous behavior that reveals the desperation and lack of education about obesity management.

Why Obesity is an Expensive, Long-Term Health Problem Employers Can't Dismiss?

Over 40% of American adults qualify for the CDC's definition of obesity, a BMI of 30 or more. The disorder is a significant cause of comorbidities such as type 2 diabetes, hypertension, and cardiovascular disease—a combination frequently called "cardiodiabesity." Alone, obesity costs the U.S. healthcare system $173 billion per year and accounts for $6.38 billion in lost productivity in the workplace.

With these daunting numbers, employers are finally realizing that managing obesity up front may be cheaper in the long term. In 2023, only 25% of employers were covering GLP-1s, but this might increase to 43% in 2024, says health consulting company Accolade.

But selling prescription medications without complementing them with health support is a lost chance. Specialists recommend a combined approach—of accessible pharmaceuticals along with dietary advice, exercise routine, psychiatric help, and regular medical follow-up.

Medical Experts Call for Balanced Approach

While the temptation of GLP-1 medications can be tempting, specialists advise against its use as a single solution. Pills can trigger weight loss, but long-term health is derived from behavioral modification. Fitch and others suggest addressing obesity as any chronic illness, with long-term, multidimensional management.

Dr. Arush emphasises, "There is a strong connecting link between type 2 diabetes and obesity. When there is excess deposition of abdominal fat, it makes the body insulin resistant. This is a condition wherein the body finds it hard to respond to insulin hormone and this in turn, surges the blood sugar levels. Ultimately this makes the body predisposed to type 2 diabetes."

Employers who are seriously interested in tackling obesity in the workplace need to look beyond providing coverage. They must make available comprehensive health packages that consist of individualized interventions, ongoing tracking, and lifestyle change support systems for enduring change.

For the time being, it appears GLP-1 medications are not only changing waistlines, but also workplaces. Workers are willing to make drastic life adjustments—including job-hopping—for access to these drugs. Whether this is a significant shift in corporate healthcare priorities or a troubling shortcut remains to be determined.

One thing is certain, the workplace is emerging as a central front in the battle against obesity. And as the stakes grow higher, so does the onus on employers to provide intelligent, sustainable, and equitable solutions for the long-term health of their employees.

Dr. Arush Sabharwal is a Bariatric & Metabolic Surgeon at SCOD Clinic in India

Flu cases are on the rise and as of the January 3, 2026 data by the Centers for Disease Control and Prevention, more than 120,000 cases have been detected in clinical laboratories, apart from those detected in home tests. About 40,000 influenza cases were admitted to the hospital in the prior week and 17 influenza-related deaths reported in children, this season. Physicians across the US are constantly telling everyone, especially the vulnerable population to keep an eye on the symptoms. They have time and again also urged people to get vaccinated against the flu. The country is also seeing an overload of flu cases, with many calling it the 'worst flu season' ever.

The 2025-2026 flu season's main culprit is the influenza A (H3N2) subclade K, or the superflu. This variant is a mutated strain of H3N2 virus and has a history of being most contagious, staying longer on surface, which is why it is driving the most numbers of hospitalization this season.

Jesse Pines, Chief of Clinical Innovation for US Acute Care Solutions and a practising physician for over 20 years of experiences writes for Forbes the 5 must-know things about the flu.

5 Must-Know Things About Flu, From An ER Doctor

Identify the Symptoms

It is important to know what symptoms you have to know about the illness. This flu starts with high fever, cough, fatigue, muscle aches, sore throat and a headache. However, not everyone can have the similar symptoms. Children could experience gastrointestinal symptoms, which include nausea, vomiting and diarrhea. Older adults may have atypical symptoms, which may include not feeling hungry, dizziness, or weakness.

Read: Face Masks Are 'Inadequate', Says WHO, Must Be Swapped For Respirators

Vaccine Is A Must

While the flu vaccine for this season was made at least 7 to 8 months before, like usually it happens, which means the subclade K strain may not be this vaccine's target. However, data shows that despite this mismatch, it has a 72 to 75% effective rate in preventing emergency department visits and hospital admissions in children and adolescents, and 32 to 39% effectiveness in adults.

What To Do If You Have Flu Symptoms

The first response should be to contact your healthcare provider for prescription. Pines note that "Oseltamivir (Tamiflu) and baloxavir (Xofluza) are primary options". These are used to reduce the symptom duration, and prevent any further complications like pneumonia. It is most effective if started with in the 48 hours of symptoms.

Should You Seek Higher-Level Medical Care With Flu?

While many people recover at home, if you see your symptoms are not showing any signs of reduction beyond 4 to 5 days, you may need a higher levels of medical care for your flu. This could also be applied if your symptoms worsen suddenly after a few days.

How to Manage Post Flu Weakness?

While everyone is talking about flu and its treatment, not much attention is paid on what to do afterwards. Even after the treatment, one might feel the weakness during their recovery period. This has a scientific name, known as 'post-viral' syndrome, which means a lingering cough and fatigue for 2 to 3 weeks after the illness. This is the time when you gradually return to normal activities, but ensure to maintain adequate hydration, sufficient calorie and protein intake in your diet and adequate sleep.

The NHS has issued an alert for anyone taking a widely used heart medication. People are being advised to watch for serious warning signs, including yellowing of the skin or “nosebleeds lasting more than 10 minutes.”

What Is Propranolol?

Propranolol is a beta blocker that slows the heart rate and relaxes blood vessels, helping lower blood pressure and reduce the heart’s oxygen demand. It is also prescribed to ease symptoms of anxiety, such as trembling or excessive sweating, and can help prevent migraines. The medication is prescription-only but is commonly prescribed throughout the UK.

According to the Mirror, the British Heart Foundation reports that more than 50 million beta blocker prescriptions are issued in the UK each year, including for propranolol. Patients usually take it once a day, in either a standard or slow-release form.

While propranolol is generally safe, it does carry possible side effects. The NHS advises contacting 111 immediately if serious symptoms affecting the blood or kidneys appear.

The NHS notes: “Like all medicines, propranolol can cause side effects in some people, but many experience none or only minor effects. Side effects often ease as your body adjusts to the medication.”

Propranolol Side Effects

Common side effects include headaches, fatigue, weakness, cold fingers or toes, nausea, and stomach discomfort. While most people over 12 can safely take propranolol, the NHS recommends consulting a doctor first if you have a history of low blood pressure, heart failure, depression, or diabetes.

More serious reactions can occur, including yellowing of the eyes or skin, pale stools, or dark urine. The NHS also warns of nosebleeds lasting longer than 10 minutes, unexplained bruising, or increased tendency to bruise easily.

Anyone experiencing these warning signs should contact a doctor or call 111 immediately. The NHS also cautions against stopping propranolol abruptly without medical guidance, as this could trigger severe heart problems, including chest pain or even a heart attack.

Who Should Be Extra Cautious With Propranolol

While propranolol is widely prescribed and generally safe for most adults, certain people need to monitor themselves more closely or consult their doctor before use. Those with low blood pressure, heart failure, slow heart rates, diabetes, respiratory conditions like asthma, or a history of depression may face higher risks of side effects. Pregnant or breastfeeding women should also speak to a healthcare professional before taking the medication.

The NHS emphasizes that even minor symptoms—like unusual fatigue, dizziness, or cold hands and feet—should not be ignored, especially if they worsen over time. Monitoring for these effects early can prevent more serious complications.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you experience any side effects or unusual symptoms while taking propranolol or any other prescription medicine, seek medical attention immediately.

A California man died last weekend after eating so-called death cap mushrooms, marking the third fatality linked to the toxic fungi in the state since November.

Health officials say California is seeing an unusually high number of mushroom poisonings this season. Between November 18 and January 4, at least 35 cases were reported statewide. In a typical year, the number is usually fewer than five.

“This year’s figures are far beyond what we normally see,” said Sheri Cardo, a communications specialist with the California Department of Public Health.

California Resident Dies After Eating Death Cap Mushrooms

At least three people have now lost their lives in California due to death cap mushroom poisoning since November. Media reports indicate a sharp rise in cases tied to foraged wild mushrooms, with more than 35 poisonings recorded over the past three months.

“The numbers we’re dealing with this year are comparatively off the charts,” Cardo told NBC News.

The most recent death occurred in Sonoma County and was the first fatal wild mushroom poisoning reported there this season, according to county health officials.

Dr. Michael Stacey, interim health officer for Sonoma County, urged residents to avoid eating wild mushrooms unless they are purchased from reliable grocery stores or licensed sellers. He warned that death cap mushrooms can look strikingly similar to safe, edible varieties.

What Is Death Cap Mushroom Poisoning?

Death cap mushrooms, scientifically known as Amanita phalloides, are among the most poisonous mushrooms in the world. They commonly grow beneath oak trees and can be found in parks, gardens, and wooded areas.

Experts say these mushrooms are often mistaken for edible types because of their appearance. Typical features include:

• A smooth cap that may appear whitish, pale yellow, light brown, or green
• White gills underneath the cap
• A white spore print
• A cup-like structure called a volva at the base of the stem
• A ring, known as an annulus, around the stem

Death Cap Mushroom Symptoms

Symptoms usually begin between six and 24 hours after ingestion. Early signs often include stomach pain, nausea, vomiting, and diarrhoea.

In many cases, symptoms ease or disappear after one or two days, which can create a false sense of recovery. By that point, however, the toxins may have already caused severe damage to the liver.

According to experts, the poison responsible, known as amatoxin, can seriously harm the liver, kidneys, and digestive system. Without prompt treatment, the damage can be fatal.

U.S. Poison Centers receive an average of about 52 calls each year related to amatoxin exposure, said Hallen-Adams, though not every case is officially reported.

Is the Risk Easing?

The danger may now be starting to decline in parts of California. Mike McCurdy, president of the Mycological Society of San Francisco, said he has noticed far fewer death cap mushrooms during recent foraging trips.

Earlier this winter, McCurdy said he spotted hundreds of death caps during a two- to three-hour walk in Sonoma County. On a recent outing near Lafayette, California, he found just one. “I think we’re getting close to the end,” he said.